Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Sep;23(9):664-6.
doi: 10.1111/jvh.12550. Epub 2016 Jun 8.

Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all

J Grebely  1 , A Litwin  2 , G J Dore  1
Affiliations
Comment

Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all

J Grebely et al. J Viral Hepat. 2016 Sep.
No abstract available

Keywords: IFN-free; PWID; drug users; hepatitis C virus; injecting; injection.

PubMed Disclaimer

Comment on

References

    1. Dore GJ, Feld JJ. Hepatitis C virus therapeutic development: in pursuit of “perfectovir”. Clin Infect Dis 2015; 60(12): 1829–1836. - PubMed
    1. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013; 10(9): 553–562. - PubMed
    1. Barua S, Greenwald R, Grebely J, Dore GJ, Swan T, Taylor LE. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med 2015; 163(3): 215–223. - PubMed
    1. AASLD/IDSA. Recommendations for Testing, Managing, and Treating Hepatitis C, 2015. Available at: http://www.hcvguidelines.org/ (Accessed May 23, 2016).
    1. European Association for Study of L. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2014; 60(2): 392–420. - PubMed

Publication types

Substances